VIGL
Price:
$3.85
Market Cap:
$152.64M
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative disea...[Read more]
Industry
Biotechnology
IPO Date
2022-01-07
Stock Exchange
NASDAQ
Ticker
VIGL
According to Vigil Neuroscience, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.39. This represents a change of -25.46% compared to the average of 11.25 of the last 4 quarters.
The mean historical Current Ratio of Vigil Neuroscience, Inc. over the last ten years is 12.62. The current 8.39 Current Ratio has changed 6.55% with respect to the historical average. Over the past ten years (40 quarters), VIGL's Current Ratio was at its highest in in the March 2022 quarter at 25.83. The Current Ratio was at its lowest in in the September 2020 quarter at 0.
Average
12.62
Median
11.57
Minimum
9.87
Maximum
17.49
Discovering the peaks and valleys of Vigil Neuroscience, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.24%
Maximum Annual Current Ratio = 17.49
Minimum Annual Increase = -40.21%
Minimum Annual Current Ratio = 9.87
Year | Current Ratio | Change |
---|---|---|
2023 | 10.45 | -40.21% |
2022 | 17.49 | 77.24% |
2021 | 9.87 | -22.19% |
The current Current Ratio of Vigil Neuroscience, Inc. (VIGL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.60
5-year avg
12.62
10-year avg
12.62
Vigil Neuroscience, Inc.’s Current Ratio is less than Molecular Partners AG (14.58), less than PMV Pharmaceuticals, Inc. (19.22), greater than Monte Rosa Therapeutics, Inc. (6.56), greater than Entrada Therapeutics, Inc. (5.70), less than Third Harmonic Bio, Inc. (41.13), less than Cullinan Oncology, Inc. (28.87), less than Edgewise Therapeutics, Inc. (30.24), greater than Rallybio Corporation (7.52), greater than PepGen Inc. (7.45), less than Tyra Biosciences, Inc. (36.46), less than Compass Therapeutics, Inc. (40.74), greater than PureTech Health plc (3.68), greater than Opthea Limited (2.94), less than Pharvaris N.V. (18.45),
Company | Current Ratio | Market cap |
---|---|---|
14.58 | $247.30M | |
19.22 | $84.75M | |
6.56 | $543.76M | |
5.70 | $661.41M | |
41.13 | $499.33M | |
28.87 | $923.57M | |
30.24 | $3.24B | |
7.52 | $42.11M | |
7.45 | $221.61M | |
36.46 | $865.41M | |
40.74 | $233.21M | |
3.68 | $498.68M | |
2.94 | $628.43M | |
18.45 | $1.28B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vigil Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vigil Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Vigil Neuroscience, Inc.'s Current Ratio?
How is the Current Ratio calculated for Vigil Neuroscience, Inc. (VIGL)?
What is the highest Current Ratio for Vigil Neuroscience, Inc. (VIGL)?
What is the 3-year average Current Ratio for Vigil Neuroscience, Inc. (VIGL)?
What is the 5-year average Current Ratio for Vigil Neuroscience, Inc. (VIGL)?
How does the current Current Ratio for Vigil Neuroscience, Inc. (VIGL) compare to its historical average?